Insider Transactions in Q4 2020 at Nektar Therapeutics (NKTR)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2020
|
Roy A Whitfield Director |
BUY
Bona fide gift
|
Indirect |
51,500
+50.0%
|
-
|
|
Dec 30
2020
|
Roy A Whitfield Director |
SELL
Bona fide gift
|
Direct |
51,500
-21.7%
|
-
|
|
Dec 18
2020
|
Gil M Labrucherie SVP, COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+13.03%
|
-
|
|
Dec 18
2020
|
John Northcott SVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,550
+11.1%
|
-
|
|
Dec 18
2020
|
Howard W Robin President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
106,650
+18.86%
|
-
|
|
Dec 18
2020
|
Jillian B. Thomsen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+8.32%
|
-
|
|
Dec 18
2020
|
Mark Andrew Wilson Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,550
+26.57%
|
-
|
|
Dec 18
2020
|
Jonathan Zalevsky Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+12.11%
|
-
|
|
Dec 15
2020
|
Myriam Curet Director |
SELL
Open market or private sale
|
Direct |
1,560
-7.5%
|
$26,520
$17.82 P/Share
|
|
Nov 23
2020
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
16,380
-6.14%
|
$262,080
$16.4 P/Share
|
|
Nov 16
2020
|
Gil M Labrucherie SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
8,276
-3.52%
|
$132,416
$16.93 P/Share
|
|
Nov 16
2020
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
11,975
-3.29%
|
$191,600
$16.93 P/Share
|
|
Nov 16
2020
|
Jillian B. Thomsen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,976
-6.97%
|
$191,616
$16.93 P/Share
|
|
Nov 16
2020
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,539
-2.99%
|
$24,624
$16.93 P/Share
|
|
Nov 16
2020
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
29,618
-10.0%
|
$473,888
$16.93 P/Share
|